CFLT vs LAB · rev $963.6M vs rev $174.4M
Confluent Inc (CFLT) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CFLT currently screens at market cap $11.13B. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CFLT and LAB stock pages for the full models.
Not investment advice.